Abstract
This article examines real-world antipsychotic use in the treatment of schizophrenia by comparing real-world prescribing with medication algorithms and guidelines, by evaluating the evidence underlying recommendations and guidelines, and by examining the roles of side effects and medication adherence in real-world prescribing decisions.
Original language | English (US) |
---|---|
Pages (from-to) | 401-416 |
Number of pages | 16 |
Journal | Psychiatric Clinics of North America |
Volume | 30 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2007 |
ASJC Scopus subject areas
- Psychiatry and Mental health